Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolates

Candida glabrata (Nakaseomyces glabratus) is the most common cause of drug-resistant candidemia and is associated with a high mortality rate. Only a few mechanisms of drug resistance are known in C. glabrata, predominantly involving recurrent single nucleotide polymorphisms. The importance of structural variation in acquired drug resistance is not understood. We performed comparative phenotypic and genomic analyses of six serial bloodstream isolates of C. glabrata and identified novel mutations associated with resistance to echinocandins. Critically, we identified a novel gene conversion event between the hotspot 2 regions of FKS1 and FKS2 that was associated with increased resistance to micafungin. We further analyzed 621 publicly available C. glabrata genomes and found three additional examples of structural variation involving FKS1 and FKS2. Ultimately, drug resistance in C. glabrata involves structural variants that are missed with current diagnostic methods and need to be considered when designing and implementing more effective antifungal management strategies.

Authors

Institutions

Publication Details

Journal
npj Antimicrobials and Resistance
Published
2025-04-17
DOI
https://doi.org/10.1038/s44259-025-00102-6
Citations
9
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
11.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolates

Nancy E. Scott, Susan L. Kline, Anna Selmecki, Serin Edwin Erayil et al.
9 citations
npj Antimicrobials and Resistance
Antifungal resistance and susceptibility
11.17
article

Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolates

Nancy E. Scott, Susan L. Kline, Anna Selmecki, Serin Edwin Erayil, Christopher Zajac
article en
9 citations

Abstract

Candida glabrata (Nakaseomyces glabratus) is the most common cause of drug-resistant candidemia and is associated with a high mortality rate. Only a few mechanisms of drug resistance are known in C. glabrata, predominantly involving recurrent single nucleotide polymorphisms. The importance of structural variation in acquired drug resistance is not understood. We performed comparative phenotypic and genomic analyses of six serial bloodstream isolates of C. glabrata and identified novel mutations associated with resistance to echinocandins. Critically, we identified a novel gene conversion event between the hotspot 2 regions of FKS1 and FKS2 that was associated with increased resistance to micafungin. We further analyzed 621 publicly available C. glabrata genomes and found three additional examples of structural variation involving FKS1 and FKS2. Ultimately, drug resistance in C. glabrata involves structural variants that are missed with current diagnostic methods and need to be considered when designing and implementing more effective antifungal management strategies.

npj Antimicrobials and ResistanceVol. 3(1)
University of Minnesota (US), University of Minnesota Medical Center (US)
National Science Foundation, Burroughs Wellcome Fund, University of Minnesota, National Institutes of Health
Zero hunger
Openalex Percentile: Top 1%
Antifungal resistance and susceptibility
11.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolates — Nancy E. Scott, Susan L. Kline, et al. · npj Antimicrobials and Resistance (2025) | TGRS Research Map | TGRS